Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBF)

Delayed Data
As of Jan 12
 -1.53 / -0.60%
Today’s Change
Today|||52-Week Range
Prothena (PRTA) Tumbles 18% in a Year: What Lies Ahead?
Jan 15 / Zacks.com - Paid Partner Content
ImmunoGen Starts Phase I Study on Leukemia Candidate IMGN632
Jan 05 / Zacks.com - Paid Partner Content
Roche MS Drug Ocrevus Gets Marketing Authorization in Europe
Jan 15 / Zacks.com - Paid Partner Content
Celsion's Phase I/II Cancer Study Initiation Gets FDA Nod
Jan 05 / Zacks.com - Paid Partner Content
FDA Approvals Surge in 2017: Here's a Look at the Numbers
Jan 09 / Zacks.com - Paid Partner Content
Cancer Space Update: New Regulatory Status for 3 Major Drugs
Jan 05 / Zacks.com - Paid Partner Content
GE Healthcare Partners Roche for Improved Critical Care
Jan 08 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Allergan Announces Job Cuts, Pfizer Inks Deals
Jan 05 / Zacks.com - Paid Partner Content
Exelixis Amends Cabozantinib-Tecentriq Phase Ib Trial
Jan 05 / Zacks.com - Paid Partner Content
3 Large-Cap Pharma Stocks to Watch Out for This New Year
Jan 04 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close255.53
Today’s open254.00
Day’s range254.00 - 254.00
Average volume (3 months)165
Market cap$40.6B
Data as of 10:45am ET, 01/12/2018

Growth & Valuation

Earnings growth (last year)+5.53%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+2.67%
P/E ratio19.1


No competitors data available.


Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$51.3B
Annual profit (last year)$9.7B
Net profit margin18.93%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Chief Financial &
Information Technology Officer
Alan Hippe
Corporate headquarters
Basel, Basel-stadt (basle Town)